In a large multicenter cohort, dual antiplatelet therapy showed the greatest 90 day benefit when started within 24 hours ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
A recent opinion paper concluded that timely revascularization and dual antiplatelet therapy (DAPT) are crucial in the ...
An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback